Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

Share Price Information for De La Rue (DLAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 90.00
Bid: 90.20
Ask: 92.60
Change: 0.60 (0.67%)
Spread: 2.40 (2.661%)
Open: 88.80
High: 91.60
Low: 88.00
Prev. Close: 89.40
DLAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2023 AGM Voting Update

7 Mar 2024 13:04

RNS Number : 0331G
De La Rue PLC
07 March 2024

7 March 2024

De La Rue plc

2023 AGM voting update

In its 2023 Annual General Meeting results announcement on 7 September 2023, De La Rue plc noted that Resolution 15, in relation to the additional dis-application of pre-emption rights, did not receive sufficient support to be passed at the AGM and received over 20% of votes against.

The Board confirmed that the resolution was entirely in line with the Statement of Principles published by the Pre-Emption Group in November 2022 and the specific authority sought would have been limited to issuance of equity for cash in connection with an acquisition or specified capital investment. The Board was aware that at the time, market practice in relation to the dis-application of pre-emption rights had yet to settle on a consensus position, notwithstanding the Austin Review of secondary capital raising and the subsequent amendment of the Statement of Principles by the Pre-Emption Group.

Subsequent to the AGM, we have engaged with our largest shareholders to understand their views on this resolution, which included that the level of authority sought could result in inappropriate levels of dilution.

The Board will continue to consult with shareholders and will keep this matter under review in determining the authorities to be sought by shareholders at the 2024 AGM.

Enquiries

De La Rue plc

+44 (0)1256 605000

Jon Messent

Company Secretary and General Counsel

Louise Rich

Head of Investor Relations

About De La Rue

Established 210 years ago, De La Rue is trusted by governments, central banks, and international brands, providing digital and physical solutions that protect their supply chains and cash cycles from counterfeiting and illicit trade.

With operations in five continents, customers in 140 countries and solutions that include advanced track and trace software, security document design, banknotes, brand protection labels, tax stamps, security features and passport bio-data pages, De La Rue brings unparalleled knowledge and expertise to its partnerships and projects.

Our core focus areas are:

- Authentication: leveraging advanced digital software solutions and security labels to protect revenues and reputations from the impacts of illicit trade, counterfeiting, and identity theft.

- Currency: designing and manufacturing highly secure banknotes and banknote components that are optimised for security, manufacturability, cash cycle efficacy and public engagement.

The security and trust derived from our solutions pave the way for robust economies and flourishing societies. This is underpinned by a significant Environmental, Social, and Governance commitment that is evidenced by accolades such as the ISO 14001 certification and a consistent ranking in the top tier of the Financial Times European Climate Leaders list.

De La Rue's shares are traded on the London Stock Exchange (LSE: DLAR). De La Rue plc's LEI code is 213800DH741LZWIJXP78. For further information please visit www.delarue.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGMXDLFBZXLBBBF
Date   Source Headline
31st May 20229:25 amRNSHolding(s) in Company
25th May 20227:00 amRNSFY22 Full Year Results
23rd May 20221:03 pmRNSAdditional Listing
7th Apr 20227:00 amRNSTrading Update
1st Apr 202210:17 amRNSTotal Voting Rights
18th Mar 20227:00 amRNSUpdate on Responsible Business Activities
11th Mar 202210:45 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPension Scheme funding update
1st Mar 202210:44 amRNSTotal Voting Rights
3rd Feb 20227:00 amRNSAuthentication Contract Win
1st Feb 20229:44 amRNSTotal Voting Rights
26th Jan 20222:46 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSTrading and Turnaround Plan Update
12th Jan 20225:48 pmRNSChange in Director's Particulars
5th Jan 20224:37 pmRNSDirector/PDMR Shareholding
4th Jan 202212:06 pmRNSBlock listing Interim Review
4th Jan 202212:02 pmRNSTotal Voting Rights
1st Dec 202111:59 amRNSTotal Voting Rights
24th Nov 20217:00 amRNS2021/22 HALF YEAR RESULTS
1st Nov 202111:55 amRNSTotal Voting Rights
15th Oct 202110:08 amRNSHolding(s) in Company
12th Oct 20217:00 amRNSTrading Statement
1st Oct 20212:24 pmRNSTotal Voting Rights
15th Sep 20217:00 amRNSAnnouncement Of Significant Expansion In Malta
1st Sep 202111:00 amRNSTotal Voting Rights
4th Aug 202111:30 amRNSHolding(s) in Company
2nd Aug 20219:58 amRNSTotal Voting Rights
29th Jul 20211:36 pmRNSResult of AGM
29th Jul 20217:00 amRNSAGM Statement
8th Jul 20212:43 pmRNSDirector/PDMR Shareholding
6th Jul 20212:51 pmRNSDirector/PDMR Shareholding
1st Jul 20214:35 pmRNSBlock listing Interim Review
1st Jul 20214:21 pmRNSTotal Voting Rights
1st Jul 20218:00 amRNSDirector/PDMR Shareholding
28th Jun 20213:55 pmRNSHolding(s) in Company
24th Jun 202111:24 amRNSHolding(s) in Company
18th Jun 20211:44 pmRNSAnnual Financial Report
1st Jun 202111:23 amRNSTotal Voting Rights
26th May 20217:00 amRNS2020/21 Full Year Results
13th May 20217:00 amRNSAUTHENTICATION CONTRACT WINS
4th May 20212:07 pmRNSTotal Voting Rights
13th Apr 20217:00 amRNSTrading Statement
1st Apr 20217:00 amRNSTotal Voting Rights
23rd Mar 20215:09 pmRNSHolding(s) in Company
23rd Mar 20217:00 amRNSDirectorate Change
1st Mar 202112:20 pmRNSTotal Voting Rights
1st Feb 202112:37 pmRNSTotal Voting Rights
28th Jan 202112:59 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSTrading Statement
5th Jan 20219:36 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.